Eileen M McMahon
About
Provided by Eileen M McMahon
Practice Areas
Eileen’s market-leading experience, practical advice and industry insight in intellectual property and regulatory law make her a go-to advisor for clients in Canada and the United States.
Chair of Torys’ Intellectual Property and Food and Drug Regulatory practices, Eileen is one of a handful of Canadian lawyers who advise on regulatory clearance and intellectual property protection of products. Across sectors—including life sciences, agribusiness, regenerative medicine and stem cells, cannabis and more—Eileen helps clients identify IP and regulatory assets, obtain and maintain market exclusivity, exploit IP assets and enforce their IP rights.
Eileen is a registered patent and trademark agent in the United States and Canada and is adroit at navigating the issues at play in cross-border matters. She is also a Certified Licensing Professional of the Licensing Executive Society (LES) (2011-2014), United States and Canada. This certification is issued only to persons who have met the requirements for licensing professionals, established by CLP, Inc., under the guidance of the LES. Fewer than 1% of all attorneys have this certification, making Eileen a specialized resource for clients.
Chambers Review
Canada
Eileen McMahon enjoys a reputation as one of Canada's foremost life sciences lawyers and is considered a go-to expert by many major pharmaceutical companies. She assists with product regulations and licensing, as well as intellectual property. She is based in Toronto, from where she leads Torys' IP and food and drug regulatory practices.
"She has been committed to our business on a professional level and is a lot of fun and interesting to work with on a personal level." "In addition to having superb command of the subject matter, Eileen immediately understands competing points of view, relates to others with ease and has great listening skills."
Eileen McMahon has cultivated an outstanding reputation in the life sciences sector, with a knowledge base spanning issues from patent law and licensing to regulatory compliance and pricing.
"She is a great patent lawyer with huge experience." "Eileen is very knowledgeable and comes informed to every discussion with a strategy in mind."
Eileen McMahon draws upon her wealth of experience handling intellectual property and regulatory matters to provide support to cannabis sector clients. Based in Toronto, she is the chair of the firm's food and drug regulatory practice.
"Eileen shows a high level of sophistication in her approach to evaluating and proposing approaches to resolving a matter." "She is a pleasure to deal with and has strong industry experience."
Articles, highlights and press releases
3 items provided by Torys LLP
Emerging Companies in Canada: Data and Digital Technology and Life Sciences
The growth of Canada’s emerging company and tech sector has been on a path of acceleration. We are also seeing increased foreign investment into the industry, particularly from America. The tech sector’s presence is being felt nationwide. Here we discuss key growth areas to watch moving forwards.
Rewiring the supply chain: how the pandemic is shaping government procurement
COVID-19 has long-term implications for how governments think about procurement. Obtaining vaccines & critical supplies was no easy feat during the pandemic. This article examines domestic production, foreign procurement and how the global supply chain is shaping public policy goals and objectives.
Torys Business Brief: A turning point for Canada’s life sciences
What lessons can be learned from the pandemic for the life sciences industry? Hear from Eileen McMahon and Cheryl Reicin and researcher Dr. Shaf Keshavjee
Emerging Companies in Canada: Data and Digital Technology and Life Sciences
The growth of Canada’s emerging company and tech sector has been on a path of acceleration. We are also seeing increased foreign investment into the industry, particularly from America. The tech sector’s presence is being felt nationwide. Here we discuss key growth areas to watch moving forwards.
Rewiring the supply chain: how the pandemic is shaping government procurement
COVID-19 has long-term implications for how governments think about procurement. Obtaining vaccines & critical supplies was no easy feat during the pandemic. This article examines domestic production, foreign procurement and how the global supply chain is shaping public policy goals and objectives.
Torys Business Brief: A turning point for Canada’s life sciences
What lessons can be learned from the pandemic for the life sciences industry? Hear from Eileen McMahon and Cheryl Reicin and researcher Dr. Shaf Keshavjee
Discover other Lawyers at
Torys LLP
Alberta
Nationwide - Canada
